Subscribe to Newsletter

Discovery & Development

Discovery & Development Clinical Trials

Clinical Trials: Decentralization and Digital Chaos

| Katrina Rice | 5 min read

Modern data strategies are needed as the landscape for clinical trials changes.

Discovery & Development Drug Discovery

James Phipps, We Salute You

| Rob Coker | 3 min read

It’s been 200 years since the death of Edward Jenner – but how best to celebrate his achievement?

Discovery & Development Drug Delivery

The Golden Age of Drug Delivery

| Cornell Stamoran | 7 min read

How are the last few years of pharmaceutical industry trends affecting the drug delivery landscape – and what opportunities should we grasp?

Discovery & Development Drug Discovery

Maps for Drug Discovery

| Stephanie Vine | 3 min read

A new technology called ASCEND is being using to help pharmaceutical research.

Discovery & Development Analytical Science

Tackling Vaccine (Im)purity

| Kerstin Pohl | 7 min read

With new vaccines come new challenges – and the need for new tools. Can mass spectrometry solve the problem of impurities?

Discovery & Development Drug Delivery

International Rescue

| Rob Coker | 3 min read

The International Vaccine Institute’s Youngmi Cho is on a mission to protect communities against diseases of poverty

Discovery & Development Ingredients

The Grand Winner

| Stephanie Vine

Voting for The Medicine Maker Innovation Awards has ended and we are delighted to announce our grand winner.

Discovery & Development Drug Discovery

To Be Precise

| Neil Ward | 3 min read

Better data brings new advances in our knowledge of genetics. PacBio VP Neil Ward explains how pharmacogenomics will accelerate precision medicine.

Discovery & Development Clinical Trials

Digitally Decentralized by Design

| Rob Coker | 3 min read

Through a partnership with software developer Medable, Syneos Health aims to decentralize and personalize clinical trials.

Discovery & Development Clinical Trials

The World’s Most Studied Disease

| Rob Coker | 5 min read

Breast cancer was the most researched disease in 2022. Phesi CEO Gen Li discusses what helps and what hinders the breast cancer research process.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register